Description
CV-66 is a 1,8-Diaza-anthracene-tetrone compound that exhibits anticancer activity, inhibiting activation of JNK and ERK5 and suppressing proliferation in various tumor cell lines.
CV-66 is a 1,8-Diaza-anthracene-tetrone compound that exhibits anticancer activity, inhibiting activation of JNK and ERK5 and suppressing proliferation in various tumor cell lines.
Purity | ≥60% |
---|---|
Formula | C14H10N2O4 |
Formula Wt. | 270.24 |
Chemical Name | 3,7-Dimethyl-9-oxido-1H-pyrido[3,2-g]quinolin-9-ium-2,5,10-trione |
IUPAC Name | 3,7-dimethyl-9-oxido-1H-pyrido[3,2-g]quinolin-9-ium-2,5,10-trione |
Synonym | Diazaanthraquinone N-oxide |
Appearance | Orange Solid |
Store Temp | -20°C |
---|---|
Ship Temp | Ambient |
MSDS | |
---|---|
Info Sheet | |
Brochures |
Pipaón C, Gutierrez P, Montero JC, et al. Mitogen-activated protein kinase routes as targets in the action of diaza-anthracene compounds with a potent growth-inhibitory effect on cancer cells. Mol Cancer Ther. 2002 Aug;1(10):811-9. PMID: 12492114.
Arp2/3 inhibitor.
EGFR (WT, T790M) inhibitor.
Synthetic progestogen, orexigenic.
SIRT inhibitor.
CRM1-selective inhibitor of nuclear export.
Wnt signaling inhibitor.
DNA-PK inhibitor.
SIRT 1 activator, SIRT3 inhibitor.
Cysteine-ITC conjugate, antioxidant; aldehyde d...
Peptide; fibrinolysis inhibitor.
CRM1/XPO1 inhibitor.
p110δ PI3K inhibitor.
14-α demethylase inhibitor.
Kawain derivative, lactone found in Piper methy...
Amino amide; voltage-gated Na+, BK/SK, Kv1, Kv3...
mAChR antagonist.
Folic acid derivative
CRTH2 inhibitor, TxA2 antagonist.
Peptide, derivative of AT I, cleavage product o...